Journal
JOURNAL OF CELL BIOLOGY
Volume 173, Issue 3, Pages 395-404Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.200510115
Keywords
-
Categories
Funding
- NCI NIH HHS [CA 100324, P01 CA100324] Funding Source: Medline
- NIGMS NIH HHS [GM38511, R01 GM038511] Funding Source: Medline
Ask authors/readers for more resources
Understanding the mechanisms controlling cancer cell invasion and metastasis constitutes a fundamental step in setting new strategies for diagnosis, prognosis, and therapy of metastatic cancers. LIM kinase1 (LIMK1) is a member of a novel class of serine-threonine protein kinases. Cofilin, a LIMK1 substrate, is essential for the regulation of actin polymerization and depolymerization during cell migration. Previous studies have made opposite conclusions as to the role of LIMK1 in tumor cell motility and metastasis, claiming either an increase or decrease in cell motility and metastasis as a result of LIMK1 over expression (Zebda, N., O. Bernard, M. Bailly, S. Welti, D. S. Lawrence, and J. S. Condeelis. 2000. J. Cell Biol. 151: 1119-1128; Davila, M., A. R. Frost, W. E. Grizzle, and R. Chakrabarti. 2003. J. Biol. Chem. 278: 36868-36875; Yoshioka, K., V. Foletta, O. Bernard, and K. Itoh. 2003. Proc. Natl. Acad. Sci. USA. 100: 7247-7252; Nishita, M., C. Tomizawa, M. Yamamoto, Y. Horita, K. Ohashi, and K. Mizuno. 2005. J. Cell Biol. 171: 349-359). We resolve this paradox by showing that the effects of LIMK1 expression on migration, intravasation, and metastasis of cancer cells can be most simply explained by its regulation of the output of the cofilin pathway. LIMK1-mediated decreases or increases in the activity of the cofilin pathway are shown to cause proportional decreases or increases in motility, intravasation, and metastasis of tumor cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available